Author:
Chada S,Mhashilkar A M,Liu Y,Nishikawa T,Bocangel D,Zheng M,Vorburger S A,Pataer A,Swisher S G,Ramesh R,Kawase K,Meyn R E,Hunt K K
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference41 articles.
1. Winer E, Morrow M, Osborne CK, Harris J . Malignant tumors of the breast. In: Devita Jr S, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology. 6th edn. VT Lippincott-Raven Publishers: Philadelphia, PA. 2000, pp 1651–1716.
2. Fisher B, Dignam J, Wolmark N, DeCillis A, Emir B, Wickerham DL et al. Tamoxifen and chemotherapy for lymph-node negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 1997; 89: 1673–1682.
3. Amat S, Bougnoux P, Penault-Llorca F, Fetissof F, Cure H, Kwiatkowski F et al. Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate. Br J Cancer 2003; 88: 1339–1345.
4. Bonnadona G . Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer. J Clin Oncol 1989; 7: 1380–1397.
5. Tantivejkul K, Vucenik I, Eiseman J, Shamsuddin AM . Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer. Breast Cancer Res Treat 2003; 79: 301–312.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献